Atlas Trials

A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors

Clinical trial NCT04547205 · COMPLETED

Trial details

NCT number
NCT04547205
Sponsor
Akeso
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2020-06-06
Primary completion
2021-03-24
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.